CLOSER inspection of the genes of alcoholics could lead to more effective, tailor-made treatments, say researchers from California and Australia. A team led by Ernest Noble of the University of California, Los Angeles, has found that a drug called bromocriptine helps some alcoholics beat their craving and avoid a relapse, but is of little benefit to others. The difference lies in their genetic make-up.
Noble and his Australian colleagues at the Royal Brisbane Hospital studied 83 Australian alcoholics who had been admitted to hospital. They found that 31 of the patients had a slightly modified version of the gene responsible for the production of a key brain protein. People with this modification are more likely to become addicted to alcohol, cocaine or nicotine, and, once addicted, find it harder to kick the habit.
Ä¢¹½Ö±²¥s think this happens because those who have this “alcoholism geneâ€� derive less pleasure from their daily activities than those with the more common version of the gene. As a result, they may be more likely to turn to drugs or drink.
Advertisement
During the trial, some of the patients were treated with bromocriptine, and some were given a placebo. Bromocriptine mimics the actions of a brain chemical called dopamine, which is believed to play a key part in the biology of addiction.
The researchers found that the patients on bromocriptine who had the “alcoholism gene� felt less anxiety and craving for alcohol during withdrawal, and had a lower rate of relapse. However, those with the other version of the gene did only slightly better than people given the placebo. This suggests that bromocriptine would not be a very useful therapy for them. Noble reports the team’s findings in this month’s issue of Nature Medicine.
Noble stresses that more research needs to be done, and is starting a larger study. But if his findings are confirmed, alcoholics may need only a simple blood test to identify the type of therapy that would suit them best. If they carry the “alcoholism gene�, they could be treated with a drug such as bromocriptine. “If not, rather than wasting money on a drug of that nature we can move into psychotherapy and other kinds of psychosocial approaches to treatment,� he says.
Like all addictions, alcoholism is hard to cure: 18 months after treatment, as many as 90 per cent of patients have fallen off the wagon. While doctors recognise that there are different “types� of addicts, sociologically and biologically, there is still a “one size fits all� approach to treatment.
“Most people who treat alcoholics would agree that there isn’t one single treatment package that fits everybody,� says Harold Kalant, of the Addiction Research Foundation of Ontario, in Toronto. “If you can individualise the treatment you stand a better chance of success.�